Surendra K Ajjarapu is Chairman and CEO of TRxADE HEALTH, INC. Currently has a direct ownership of 1.16 Million shares of MEDS, which is worth approximately $8.06 Million. The most recent transaction as insider was on Sep 01, 2022, when has been sold 51,724 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.16M
0% 3M change
0% 12M change
Total Value Held $8.06 Million

SURENDRA K AJJARAPU Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 01 2022
BUY
Grant, award, or other acquisition
-
51,724 Added 4.25%
1,164,240 Common Stock

Also insider at

AEHA
Aesther Healthcare Acquisition Corp. Financial Services
LGSTW
Semper Paratus Acquisition Corp Financial Services
SKA

Surendra K Ajjarapu

Chairman and CEO
Lutz, FL

Track Institutional and Insider Activities on MEDS

Follow TRxADE HEALTH, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MEDS shares.

Notify only if

Insider Trading

Get notified when an T Rx Ade Health, Inc insider buys or sells MEDS shares.

Notify only if

News

Receive news related to TRxADE HEALTH, INC

Track Activities on MEDS